The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. AnaptysBio Inc shares valued at $348,213 were purchased by ERIC J LOUMEAU on Jan 07 ’26. At $45.69 per share, ERIC J LOUMEAU acquired 7,622 shares.
Also, Faga Daniel sold 15,309 shares, netting a total of over 662,267 in proceeds. Following the sale of shares at $43.26 each, the insider now holds 458,139 shares.
Before that, Daniel Faga had added 15,309 shares to its account. In a trade valued at $688,140, the Officer bought AnaptysBio Inc shares for $44.95 each.
Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid October. As of June 04, 2025, H.C. Wainwright has increased its “Neutral” rating to a “Buy” for ANAB. Earlier on February 04, 2025, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for ANAB stock.
Analyzing ANAB Stock Performance
On last trading session, AnaptysBio Inc [NASDAQ: ANAB] rose 2.96% to $45.21. The stock’s lowest price that day was $43.59, but it reached a high of $47.36 in the same session. During the last five days, there has been a drop of approximately -6.26%. Over the course of the year, AnaptysBio Inc shares have jumped approximately 209.66%. Shares of the company reached a 52-week high of $48.57 on 01/02/26 and a 52-week low of $42.00 on 01/06/26.
Support And Resistance Levels for AnaptysBio Inc (ANAB)
According to the 24-hour chart, there is a support level at 43.41, which, if violated, would cause prices to drop to 41.62. In the upper region, resistance lies at 47.18. The next price resistance is at 49.16. RSI (Relative Strength Index) is 50.43 on the 14-day chart, showing neutral technical sentiment.
Is AnaptysBio Inc subject to short interest?
Stocks of AnaptysBio Inc saw a sharp steep in short interest on 2025-12-15 dropping by -0.29 million shares to 5.64 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 5.93 million shares. A decline of -5.07% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 10.19 of the overall float, the days-to-cover ratio (short ratio) decline to 10.19.
Which companies own the most shares of AnaptysBio Inc (ANAB)?
In terms of AnaptysBio Inc share price expectations, FactSet research, analysts set an average price target of 56 in the next 12 months, up nearly 27.53% from the previous closing price of $43.91. Analysts anticipate AnaptysBio Inc stock to reach 140 by 2026, with the lowest price target being 36. In spite of this, 6 analysts ranked AnaptysBio Inc stock as Buy at the end of 2026. On December 11, 2024, H.C. Wainwright assigned a price target of “a Neutral” to the stock and downgraded coverage with a $19.
